natgillin/translations-raw huggingface dataset:
4.4 Special warnings and precautions for use 
4.4 Posebna opozorila in previdnostni ukrepi Krvavitve in hematološke motnje
What Clopidogrel Teva Generics B.V. is and what it is used for Before you take Clopidogrel Teva Generics B.V. How to take Clopidogrel Teva Generics B.V. 
in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzel zdravilo Klopidogrel Teva Generics B.V.
Consequently, NSAIDs including Cox-2 inhibitors and clopidogrel should be co-administered with caution (see section 4.4). 
Zato moramo biti previdni pri sočasni uporabi nesteroidnih protivnetnih zdravil, vključno z zaviralci COX-2 in klopidogrela (glejte poglavje 4.4).
However, patients entered into clinical trials with clopidogrel received a variety of concomitant medicinal products including diuretics, beta blockers, 
Vendar pa so bolniki, ki so bili vključeni v klinično preizkušanje klopidogrela, brez dokazov o klinično pomembnih neželenih interakcijah sočasno jemali različna zdravila, tudi diuretike, zaviralce adrenergičnih receptorjev beta, zaviralce angiotenzinske konvertaze (ACE), kalcijeve antagoniste, učinkovine za zniževanje holesterola,
In CLARITY, there was an overall increase in bleeding in the clopidogrel + ASA group (17.4%) vs. the placebo + ASA group (12.9%). 
V študiji CLARITY je v skupini bolnikov, ki so se zdravili s klopidogrelom in ASA, prišlo do splošnega povečanja krvavitev (17,4%%) v primerjavi s skupino, ki je jemala placebo in ASA
Glomerulonephritis, blood creatinine increased 
Bolezni sečil glomerulonefritis,
Do not take Clopidogrel Teva Generics B.V. 
Ne jemljite zdravila Klopidogrel Teva Generics B.V.
Thrombotic thrombocytopenic purpura (TTP) (see section 4.4), aplastic anaemia, pancytopenia, agranulocytosis, severe thrombocytopenia, granulocytopenia, anaemia 
4.4), aplastična anemija, pancitopenija, agranulocitoza, huda trombocitopenija, granulocitopenija, anemija
The number of patients experiencing the primary endpoint [cardiovascular (CV) death, myocardial infarction (MI), or stroke] was 582 (9.3%) in the clopidogrel-treated group and 719 (11.4%) in the placebo-treated group, a 20% relative risk reduction (95% CI of 10%-28%; p=0.00009) for the clopidogrel-treated group (17% relative risk reduction when patients were treated conservatively, 29% when they underwent percutaneous transluminal coronary angioplasty (PTCA) with or without stent and 10% when they underwent coronary artery bypass graft (CABG)). 
Delež bolnikov s primarnim opazovanim dogodkom [srčno-žilna (SŽ) smrt, miokardni infarkt (MI) ali kap] je bil 582 (9,3%) v skupini, zdravljeni s klopidogrelom, in 719 (11,4%) v skupini, ki je prejemala placebo, to je 20% zmanjšanje relativnega tveganja (95% IZ od 10% - 28%; p=0,00009) v skupini,
Mean inhibition of platelet aggregation (IPA) with 5 μM ADP was diminished by 39% (24 hours) and 21% (Day 5) when clopidogrel and omeprazole were administered together. 
Če sta bila klopidogrel in omeprazol uporabljena skupaj, se je povprečno zavrtje agregacije trombocitov (IPA) s 5 μM ADP zmanjšalo za 39% (24 ur) oz. 21%
A number of other clinical studies have been conducted with clopidogrel and other concomitant medicinal products to investigate the potential for pharmacodynamic and pharmacokinetic interactions. 
Da bi proučili možnosti za farmakodinamične in farmakokinetične interakcije, so številne klinične študije izvedli tudi z drugimi zdravili.
Take special care with Clopidogrel Teva Generics B.V. 
Bodite posebno pozorni pri jemanju zdravila Klopidogrel Teva Generics B.V.
What Clopidogrel Teva Generics B.V. looks like and contents of the pack The film-coated tablets are pink, round and slightly convex. 
Filmsko obložente tablete so rožnate, okrogle in rahlo izbočene.
NAME OF THE MARKETING AUTHORISATION HOLDER Teva Generics B.V. 
IME IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM Teva Generics B.V.
Ελλάδα 
Jetrna okvara
ACEI, calcium antagonists, cholesterol lowering agents, coronary vasodilators, antidiabetic agents (including insulin), antiepileptic agents, and GPIIb/IIIa antagonists without evidence of clinically significant adverse interactions. 
koronarne vazodilatatorje, antidiabetike (tudi insulin), antiepileptične učinkovine in antagoniste glikoproteinov IIb/IIIa.
BEFORE YOU TAKE CLOPIDOGREL TEVA GENERICS B.V. 
preden boste vzeli zdravilo Klopidogrel Teva Generics B.V.
Clopidogrel Teva Generics B.V. is taken to prevent blood clots (thrombi) forming in hardened blood vessels (arteries), a process known as atherothrombosis, which can lead to atherothrombotic events (such as stroke, heart attack, or death). 
Proces je znan kot aterotromboza in lahko povzroči aterotrombotične dogodke (kot so kap, srčni napad ali smrt).
If any of the situations mentioned below apply to you, you should tell your doctor before taking Clopidogrel Teva Generics B.V.: 
Če katerokoli od spodaj navedenih stanj velja za vas, morate o tem obvestiti svojega zdravnika,
Nervous system disorders 
Bolezni živčevja motnje okusa
Therefore clopidogrel should be used with caution in these patients (see section 4.2). 
Ledvična okvara Zaradi pomanjkanja izkušenj pri zdravljenju bolnikov z ledvično okvaro klopidogrel tem bolnikom dajemo previdno (glejte poglavje 4.2).
- signs of liver problems such as yellowing of the skin and/or the eyes (jaundice), whether or not associated with bleeding which appears under the skin as red pinpoint dots and/or confusion (see section 2 ‘Take special care with Clopidogrel Teva Generics B.V.'). 
- zvišana telesna temperatura, znaki okužbe ali huda utrujenost, kar so znaki redkega zmanjšanja števila določenih krvnih celic; - znaki jetrnih težav, npr. porumenelost kože in/ali oči (zlatenica), ki so lahko povezani s krvavitvijo, ki se pojavi pod kožo kot drobne rdeče pike, in/ali zmedenostjo (glejte poglavje 2
- The other ingredients are microcrystalline cellulose, colloidal anhydrous silica, crospovidone (type A), macrogol 6000, hydrogenated castor oil in the tablet core and hydroxypropylcellulose (E463), titanium dioxide (E171), red iron oxide (E172), talc and propylene glycol in the filmcoating. 
(E464), titanov dioksid (E171), rdeči železov oksid (E172), smukec ter propilenglikol v filmski oblogi.
Contact your doctor or pharmacist before stopping. 
Preden prekinete zdravljenje, se posvetujte se s svojim zdravnikom ali farmacevtom.
Glycoprotein IIb/IIIa inhibitors: clopidogrel should be used with caution in patients who receive concomitant glycoprotein IIb/IIIa inhibitors (see section 4.4). 
Klopidogrel previdno dajemo bolnikom, ki sočasnega jemljejo zaviralce glikoproteina IIb/IIIa (glejte poglavje 4.4).
Neutropenia, including severe neutropenia 
vključno z motnjami labirinta vrtoglavica
PSURs 
Heparin.
HOW TO TAKE CLOPIDOGREL TEVA GENERICS B.V. 
KAKO JEMATI ZDRAVILO KLOPIDOGREL TEVA GENERICS B.V.
Driving and using machines Clopidogrel Teva Generics B.V. is unlikely to affect your ability to drive or to use machines. 
Posvetujete se z zdravnikom ali s farmacevtom, preden vzamete katerokoli zdravilo Vpliv na sposobnost upravljanja vozil in strojev Ni verjetno, da bi zdravilo Klopidogrel Teva Generics B.V.
Gastrointestinal and retroperitoneal haemorrhage with fatal outcome, pancreatitis, colitis (including ulcerative or lymphocytic colitis), stomatitis 
(vključno z ulceroznim ali limfocitnim kolitisom), stomatitis
The PSUR submission schedule for Clopidogrel Teva Generics B.V. should follow the PSURs submission schedule for the reference medicinal product. 
Razpored predložitve PSUR za Klopidogrel Teva Generics B.V.
A pharmacodynamic interaction between clopidogrel and heparin is possible, leading to increased risk of bleeding. 
Farmakodinamična interakcija med klopidogrelom in heparinom je možna in poveča tveganje za krvavitev, zato se za sočasno uporabo odločamo previdno (glejte poglavje 4.4).
Uncommon side effects (affects 1 to 10 patients in 1,000): Headache, stomach ulcer, vomiting, nausea, constipation, excessive gas in stomach or intestines, rashes, itching, dizziness, sensation of tingling and numbness. 
bruhanje, slabost, zaprtost, preveč plinov v želodcu ali črevesju, izpuščaji, srbenje, omotica, občutek mravljinčenja in otopelosti..
NAME OF THE MEDICINAL PRODUCT Clopidogrel Teva Generics B.V. 75 mg film-coated tablets Clopidogrel 
Nato je običajni odmerek ena 75-mg tableta zdravila Klopidogrel Teva Generics B.V.
Tablet core: 
Pomožna snov:
How to store Clopidogrel Teva Generics B.V. 
Kako jemati zdravilo Klopidogrel Teva Generics B.V.
However, if you are concerned by your bleeding, you should contact your doctor straightaway (see section 2 ‘Take special care with Clopidogrel Teva Generics B.V.'). 
Pri manjših vrezninah ali poškodbah, npr. če se urežete ali brijete, navadno ni razloga za skrb, če pa ste glede krvavitve v kakršnihkoli dvomih, se morate takoj posvetovati s svojim zdravnikom, (glejte poglavje 2 »Bodite posebno pozorni pri jemanju zdravila Klopidogrel Teva Generics B.V.«).
Taking Clopidogrel Teva Generics B.V. with food and drink Clopidogrel Teva Generics B.V. may be taken with or without food. 
skupaj s hrano in pijačo Zdravilo Klopidogrel Teva Generics B.V.
General disorders and administration site conditions 
Splošne težave in spremembe na mestu aplikacije zvišana telesna temperatura
For minor cuts and injuries e.g., cutting yourself, shaving, this is usually of no concern. 
Pri manjših urezninah ali poškodbah, npr. pri britju, navadno ni razloga za skrb, če pa vas glede krvavitve skrbi, se nemudoma posvetujte z zdravnikom (glejte »Možni neželeni učinki«);
INFORMATION IN BRAILLE Clopidogrel Teva Generics B.V. 75 mg 
PODATKI V BRAILLOVI PISAVI Klopidogrel Teva Generics B.V.
Like all medicines, Clopidogrel Teva Generics B.V. can cause side effects, although not everybody gets them. 
Kot vsa zdravila ima lahko tudi zdravilo Klopidogrel Teva Generics B.V.
Gastrointestinal haemorrhage, diarrhoea, abdominal pain, dyspepsia 
Bolezni dihal, prsnega koša in mediastinalnega prostora epistaksa krvavitve v dihalih
Thrombocytopenia, leucopenia, eosinophilia 
Bolezni krvi in limfatičnega sistema trombocitopenija, levkopenija, eozinofilija nevtropenija,
If you stop taking Clopidogrel Teva Generics B.V. Do not stop the treatment. 
Klopidogrel Teva Generics B.V., ne dojijo.
- Keep this leaflet. 
Ne prekinite zdravljenja.
Excipients 
ZDRAVILA
Important information about some of the ingredients of Clopidogrel Teva Generics B.V. Clopidogrel Teva Generics B.V. contains hydrogenated castor oil which may cause stomach upset and diarrhoea. 
Pomembne informacije o nekaterih sestavinah zdravila Klopidogrel Teva Generics B.V.
Since clopidogrel is metabolised to its active metabolite partly by CYP2C19, use of medicinal products that inhibit the activity of this enzyme would be expected to result in reduced drug levels of the active metabolite of clopidogrel. 
Zato je mogoče pričakovati, da uporaba zdravil, ki zavrejo delovanje tega encima, zmanjša koncentracijo aktivnega presnovka klopidogrela.
National Competent Authorities, coordinated by the Reference Member State where applicable, shall ensure that the following conditions are fulfilled by the Marketing Authorisation Holders: 
Pristojni nacionalni organi, katerih delo usklajuje referenčna država članica, kadar je ustrezno, zagotovijo, da imetniki dovoljenj za promet z zdravilom izpolnjujejo naslednje pogoje:
The final study report should be submitted to the National Competent Authorities by December 2016. 
Končno poročilo o študiji se Odboru za zdravila za uporabo v humani medicini predloži do decembra leta 2016.
A case-control study shall be performed to further investigate the possibility of an association between pholcodine use and NMBA-related anaphylactic reactions. 
Izvede se študija s „kontrolno skupino“, s katero se nadalje razišče morebitna povezava med uporabo folkodina in anafilaktičnimi reakcijami, povezanimi z živčno-mišičnimi blokatorji.
Annex III Conditions of the marketing authorisation 
Pogoji dovoljenja za promet z zdravilom
A draft protocol should be submitted to CHMP for assessment and approval within 3 months of the Commission Decision. 
V treh mesecih od odločbe Komisije se Odboru za zdravila za uporabo v humani medicini predloži osnutek protokola v ocenitev in odobritev.
This check may be repeated at intervals. 
To preverjanje se lahko ponavlja v presledkih.
Absolute bioavailability is greater than 80%. 
Absolutna biološka uporabnost je večja od 80 %.
Date of first authorisation: 26 March 2012 Date of latest renewal: 17 February 2017 
Datum prve odobritve: 26. marec 2012 Datum zadnjega podaljšanja: 17. februar 2017
- if you have blood in your urine that your doctor has not checked. 
- če imate kri v urinu, ki ga zdravnik ni preiskal.
The estimated volume of distribution in humans is 0.25 l/kg. 
Ocenjeni volumen porazdelitve pri človeku je 0,25 l/kg.
If you experience any of these, especially if you are over the age of 65, seek medical advice straight away. 
Če opazite karkoli od tega, še posebej če ste stari več kot 65 let, takoj poiščite nasvet zdravnika.
Your doctor will take this into account when treating your diabetes. 
Vaš zdravnik bo to upošteval pri zdravljenju vaše sladkorne bolezni.
Although in very rare cases fatal outcome has been reported, causal relationship has not been established. 
Čeprav so v zelo redkih primerih poročali o smrtnem izidu, vzročno razmerje ni bilo ugotovljeno.
Use in children and adolescents under 18 years is not recommended. 
Uporabe zdravila pri otrocih in mladostnikih mlajših od 18 let ne priporočamo.
Your blood sugar could fall below the normal level and can be increased by taking sugar. 
Vaš krvni sladkor lahko pade pod normalno raven in se lahko poveča z zaužitjem sladkorja.
Balkanpharma Dupnitsa AD 3 Samokovsko Shosse Str., Dupnitsa 2600, Bulgaria 
Balkanpharma Dupnitsa AD 3 Samokovsko Shosse Str., Dupnitsa 2600, Bolgarija
This is the diabetes that usually develops in adulthood. 
Ta vrsta sladkorne bolezni se običajno razvije v odrasli dobi.
- if you retain water (fluid retention) or have heart failure problems, in particular if you are over 75 years old. 
- če zadržujete vodo (zastajanje tekočine v telesu) ali imate probleme s srčnim popuščanjem, zlasti če ste starejši od 75 let.
The maximum reported dose of 120 mg/day for four days, then 180 mg/day for seven days was not associated with any symptoms. 
Najvišji poročani odmerek 120 mg/dan štiri dni, zatem pa 180 mg/dan sedem dni ni bil povezan s kakšnimi simptomi.
Do not take a double dose to make up for a forgotten tablet. 
Ne vzemite dvojnega odmerka, da bi nadomestili izpuščeno tableto.
- if you have or have ever had bladder cancer. 
- če imate ali ste imeli rak mehurja.
• Additional risk minimisation measures 
Dodatni ukrepi za zmanjševanje tveganj
However patients who experience visual disturbance should be cautious when driving or using machines. 
Vendar pa morajo biti bolniki, ki so imeli motnje vida, previdni pri vožnji ali upravljanju s stroji.
- if you have a problem with your liver or heart. 
- če imate težave z jetri ali s srcem.
Your doctor will advise you to discontinue this medicine. 
Zdravnik vam bo svetoval, da prenehate z jemanjem tega zdravila.
not known not known not known not known not known 
neznana neznana neznana neznana neznana
In particular, patients have experienced the following serious side effects: 
Konkretno so bili pri pacientih opaženi naslednji resnejši neželeni učinki:
Patients should be advised to adhere strictly to a calorie-controlled diet. 
Bolnikom je treba svetovati, da se strogo držijo kalorijsko kontrolirane diete.
Your doctor will check whether Pioglitazone Teva is working 3 to 6 months after you start taking it. 
Zdravnik bo preveril, ali zdravilo Pioglitazone Teva deluje, 3 do 6 mesecev po tem, ko začnete jemati zdravilo.
The safety and efficacy of pioglitazone in children and adolescents under 18 years of age have not been established. 
Varnost in učinkovitost pioglitazona pri otrocih in mladostnikih, mlajših od 18 let, ni potrjena.
You may take your tablets with or without food. 
Tablete lahko zaužijete s hrano ali brez nje.
Your doctor will tell you the dose to take. 
Zdravnik vam bo predpisal odmerek, ki ga morate jemati.
You may also experience a reduction in blood count (anaemia). 
Prav tako lahko pride do zmanjšanja števila krvnih celic (anemija).
The relevance to humans of the tumourigenic findings in the male rat cannot be excluded. 
Pomena za ljudi glede tumorogenih ugotovitev pri samcih podgan, ni mogoče izključiti.
This medicine will not affect your ability to drive or use machines but take care if you experience abnormal vision. 
To zdravilo ne bo vplivalo na vašo sposobnost vožnje ali upravljanja strojev, vendar bodite pozorni če imate motnje vida.
Pioglitazone and all active metabolites are extensively bound to plasma protein (> 99%). 
Pioglitazon in vsi aktivni presnovki se v veliki meri vežejo na plazemske beljakovine (> 99 %).
This study showed an increase in reports of heart failure, however this did not lead to an increase in mortality in this study. 
Ta študija je pokazala povečanje poročil srčnega popuščanja, vendar to ni vodilo k dvigu smrtnosti v tej študiji.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. 
Obvestite zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali, ali pa boste morda začeli jemati katero koli drugo zdravilo.
Part of the treatment of diabetes is dietary control. 
Del zdravljenja sladkorne bolezni je kontrola prehrane.
Your blood sugar will be checked, and your dose of Pioglitazone Teva may need to be changed. 
Preverili bodo raven vašega krvnega sladkorja in vaš odmerek zdravila Pioglitazon Teva bo morda potrebno spremeniti.
Almost half of the patients had a previous myocardial infarction and approximately 20% had had a stroke. 
Skoraj polovica bolnikov je predhodno doživela miokardni infarkt in približno 20 % je doživelo kap.
The oedema rates for comparator groups (sulphonylurea, metformin) were 2-5%. 
Stopnje pojavnosti edemov primerjalnih skupin (sulfonilsečnina, metformin) so bile 2-5 %.
Many of these patients reported concurrent peripheral oedema. 
Mnogo teh bolnikov je poročalo o sočasnem perifernem edemu.
Almost all subjects (95%) were receiving cardiovascular medicinal products (beta blockers, ACE inhibitors, angiotensin II antagonists, calcium channel blockers, nitrates, diuretics, aspirin, statins, fibrates). 
Skoraj vse osebe (95 %) so prejemale kardiovaskularna zdravila (beta blokatorje, ACE inhibitorje, antagoniste angiotenzina II, zaviralce kalcijevih kanalčkov, nitrate, diuretike, aspirin, statine, fibrate),
The European Medicines Agency has waived the obligation to submit the results of studies with pioglitazone in all subsets of the paediatric population in Type 2 Diabetes Mellitus. 
Evropska agencija za zdravila je opustila obveznost predložitve rezultatov študij z pioglitazonom pri vseh podskupinah pediatrične populacije z diabetesom tipa 2.
- if you have heart failure or have had heart failure in the past. 
- če imate srčno popuščanje ali ste imeli srčno popuščanje v preteklosti.
The relevance of such a mechanism in humans is unclear and pioglitazone should not be used in pregnancy. 
Pomen takega mehanizma pri ljudeh ni jasen, pioglitazona pa se med nosečnostjo ne sme uporabljati.
Pioglitazone tablets are taken orally once daily with or without food. 
Tablete, ki vsebujejo pioglitazon se jemljejo peroralno enkrat dnevno s hrano ali brez nje.
- if you have a special type of diabetic eye disease called macular oedema (swelling of the back of the eye). 
- če imate poseben tip diabetične očesne bolezni imenovane makularni edem (oteklina očesnega ozadja).
Pioglitazone Teva has no or negligible influence on the ability to drive and use machines. 
Zdravilo Pioglitazon Teva nima ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja s stroji.
Pioglitazone Teva helps control the level of sugar in your blood when you have type 2 diabetes by helping your body make better use of the insulin it produces. 
Zdravilo Pioglitazon Teva pomaga nadzorovati raven sladkorja v krvi, če imate sladkorno bolezen tipa 2, in sicer tako, da telesu pomaga bolje izkoristiti insulin, ki ga izdela.
If you have a serious allergic reaction, including hives and swelling of the face, lips, tongue, or throat that may cause difficulty in breathing or swallowing stop taking this medicine and talk to your doctor as soon as possible. 
Če imate resno alergijsko reakcijo, ki vključuje koprivnico in otekanje obraza, ustnic, jezika ali grla, ki lahko povzroča težave z dihanjem ali požiranjem, takoj prenehajte z jemanjem tega zdravila in se nemudoma pogovorite s svojim zdravnikom.
It is unclear whether or not there is a direct association between pioglitazone and macular oedema but prescribers should be alert to the possibility of macular oedema if patients report disturbances in visual acuity; an appropriate ophthalmological referral should be considered. 
Ni jasno ali obstaja neposredna povezava med pioglitazonom in makularnim edemom, vendar pa morajo biti zdravniki pozorni na možnost makularnega edema, če bolnik poroča o motnjah vidne ostrine; upoštevati je treba ustrezno oftamolmološko mnenje.
This is similar to that seen in a sulphonylurea active comparator group. 
To je podobno opažanjem v primerjalni skupini s sulfonilsečnino.
If ALT levels remain > 3 X the upper limit of normal, therapy should be discontinued. 
Če ravni ALT ostanejo > 3-kratne zgornje meje normalnih vrednosti, je treba zdravljenje prekiniti.
In some cases weight increase may be a symptom of cardiac failure, therefore weight should be closely monitored. 
V nekaterih primerih je povečanje telesne mase lahko simptom srčnega popuščanja, zato je treba telesno maso skrbno spremljati.
- if you are allergic to pioglitazone or any of the other ingredients of this medicine (listed in section 6). 
- če ste preobčutljivi na pioglitazon ali katero koli sestavino tega zdravila (navedeno v poglavju
In light of age- related risks (especially bladder cancer, fractures and heart failure), the balance of benefits and risks should be considered carefully both before and during treatment in the elderly. 
Glede na s starostjo povezana tveganja (zlasti rak mehurja, zlomi in srčno popuščanje), je treba pri starejših ravnovesje med koristmi in tveganji skrbno pretehtati pred in med zdravljenjem.
A higher number of bone fractures was seen in patients, particularly women taking pioglitazone. 
Opazili so večje število zlomov kosti še zlasti pri ženskah, ki so jemale pioglitazon.
Interactions with substances metabolised by these enzymes, e.g. oral contraceptives, cyclosporin, calcium channel blockers, and HMGCoA reductase inhibitors are not to be expected. 
Interakcij s snovmi, ki jih presnavljajo ti encimi, npr. s peroralnimi kontracepcijskimi sredstvi, ciklosporinom, zaviralci kalcijevih kanalčkov in inhibitorji HMGCoA reduktaze, ni pričakovati.
If patients report hypoglycaemia, the dose of insulin should be decreased. 
Če bolniki poročajo o hipoglikemiji, je treba odmerek insulina znižati.
As a consequence of increased insulin sensitivity, patients receiving pioglitazone in dual or triple oral therapy with a sulphonylurea or in dual therapy with insulin may be at risk for dose-related hypoglycaemia, and a reduction in the dose of the sulphonylurea or insulin may be necessary. 
Kot posledica povečane občutljivosti na insulin, so lahko bolniki, ki prejemajo pioglitazon v dvojnem ali trojnem zdravljenju s sulfonilsečnino ali v dvojnem zdravljenju z insulinom, izpostavljeni tveganju za od odmerka odvisno hipoglikemijo, in je morda potrebno znižati odmerek sulfonilsečnine ali insulina.
If you have the impression that the effect of Pioglitazone Teva is too weak, talk to your doctor. 
Če menite, da je učinek zdravila Pioglitazon Teva prešibak, se posvetujte z zdravnikom.
If you take Pioglitazone Teva with other medicines for diabetes, it is more likely that your blood sugar could fall below the normal level (hypoglycaemia). 
Če ste vzeli zdravilo Pioglitazon Teva z drugimi zdravili za zdravljenje sladkorne bolezni, je bolj verjetno, da vrednost vašega krvnega sladkorja pade pod normalno raven (hipoglikemija).